VCIM
GOSS icon

Velan Capital Investment Management’s Gossamer Bio GOSS Stock Holding History

Velan Capital Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23K Hold
70,000
– – 0.01% 49
2025
Q4 		$217K Hold
70,000
– – 0.13% 34
2025
Q3 		$184K Sell
70,000
-5,000
-7% -$11K 0.17% 31
2025
Q2 		$92.3K Hold
75,000
– – 0.09% 35
2025
Q1 		$82.5K Hold
75,000
– – 0.08% 31
2024
Q4 		$67.8K Buy
+75,000
New +$64.3K 0.06% 32
2023
Q4 		– Sell
-3,065,136
Closed -$2.55M – 25
2023
Q3 		$2.55M Buy
+3,065,136
New +$3.53M 2.06% 14

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Velan Capital Investment Management's GOSS Position: Q1 2026 in Review

Velan Capital Investment Management held its Gossamer Bio (GOSS) position steady in Q1 2026 at 70,000 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #49.

Velan Capital Investment Management first reported a position in GOSS in Q3 2023 and has held it in 7 quarters since. The position peaked at $2.55M in Q3 2023. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Velan Capital Investment Management held 70,000 shares of Gossamer Bio worth $23K as of Q1 2026.
  • Velan Capital Investment Management left its Gossamer Bio share count unchanged in Q1 2026.
  • Gossamer Bio made up 0.01% of Velan Capital Investment Management's portfolio in Q1 2026, its #49 holding.
  • Velan Capital Investment Management first reported a position in Gossamer Bio in Q3 2023 and has held it in 7 quarters since.
  • Velan Capital Investment Management's Gossamer Bio position peaked at $2.55M in Q3 2023.
  • 185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.